|
||||||||||||||||
|
||||||||||||||||
The following HTML text is provided to enhance online readability. Many aspects of typography translate only awkwardly to HTML. Please use the page image as the authoritative form to ensure accuracy. ABBREVIATIONSABC abacavir ACTG AIDS Clinical Trials Group AIDS acquired immunodeficiency syndrome ALT alanine aminotransferase ART antiretroviral therapy ARV antiretroviral ATV atazanavir bid twice daily CD4 T-lymphocyte CD4+ CNS central nervous system d4T stavudine DART development of antiretroviral therapy in Africa ddI didanosine DOT directly observed therapy EFV efavirenz ENF (T-20) enfuvirtide FBC full blood count FDC fixed-dose combination FTC emtricitabine GI gastrointestinal HAART highly active antiretroviral therapy Hgb haemoglobin HIV human immunodeficiency virus HIVab human immunodeficiency virus antibody IDU injecting drug user IDV indinavir LPV lopinavir MTCT mother-to-child transmission (of HIV) NAM nucleoside analogue mutation NFV nelfinavir NGO nongovernmental organization NNRTI non-nucleoside reverse transcriptase inhibitor NsRTI nucleoside analogue reverse transcriptase inhibitor NtRTI nucleotide analogue reverse transcriptase inhibitor NVP nevirapine PCR polymerase chain reaction PI protease inhibitor qd once daily RT reverse transcriptase RTI reverse transcriptase inhibitor RTV ritonavir
|
|
|||||||||||||||
